Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$64.85 - $71.7 $1,815 - $2,007
-28 Reduced 0.88%
3,151 $213,000
Q2 2023

Jul 19, 2023

SELL
$69.91 - $75.81 $23,629 - $25,623
-338 Reduced 9.61%
3,179 $227,000
Q1 2023

Apr 25, 2023

BUY
$63.15 - $71.6 $14,587 - $16,539
231 Added 7.03%
3,517 $244,000
Q4 2022

Jan 24, 2023

BUY
$54.21 - $70.44 $178,134 - $231,465
3,286 New
3,286 $0
Q2 2022

Aug 09, 2022

BUY
$59.26 - $71.14 $78,697 - $94,473
1,328 Added 9.83%
14,835 $980,000
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $51,819 - $62,421
-930 Reduced 6.44%
13,507 $896,000
Q3 2021

Oct 25, 2021

BUY
$55.56 - $60.79 $52,226 - $57,142
940 Added 6.96%
14,437 $867,000
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $56,941 - $70,771
-1,176 Reduced 8.01%
13,497 $808,000
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $14,478 - $16,713
-307 Reduced 2.05%
14,673 $729,000
Q4 2020

Feb 18, 2021

BUY
$48.52 - $58.02 $46,336 - $55,409
955 Added 6.81%
14,980 $749,000
Q3 2020

Nov 23, 2020

BUY
$53.07 - $61.1 $709,811 - $817,212
13,375 Added 2057.69%
14,025 $769,000
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $452,952 - $521,488
-8,535 Reduced 92.92%
650 $67,000
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $56,504 - $72,511
1,311 Added 16.65%
9,185 $486,000
Q1 2020

May 05, 2020

BUY
$37.79 - $51.33 $188,950 - $256,650
5,000 Added 173.97%
7,874 $352,000
Q4 2019

May 05, 2020

BUY
$42.46 - $50.46 $122,030 - $145,022
2,874 New
2,874 $143,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.